Hi [[ session.user.profile.firstName ]]

WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents

Challenging patents involving unpredictable technologies for obviousness is particularly difficult due to the well-established factor of “reasonable expectation of success” and the related KSR factor of “limited number of predictable solutions”. This webinar, presented by attorneys that have successfully argued on both sides of this issue for chem/pharma/bio patents, will discuss two to three leading PTAB decisions, including related appeals, that illustrate when obviousness challenges have and have not been successful. The case discussions will provide (1) a summary of the documentary evidence relied on, including critical excerpts from that evidence, (2) a summary of the “story” that was being told by each party and (3) the role that expert testimony appeared to play in the PTAB decisions. This one-hour seminar will also briefly explore what types of cases are better challenged in court and what types of cases are better challenged at the PTAB. The goals of the seminar are to allow parties to evaluate the chances of success for a contemplated or recently filed PTAB challenge and to help parties to a PTAB proceeding develop a record to support their respective positions. CLE available.
Recorded Oct 13 2016 66 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Gerald Murphy (BSKB), Eugene Perez (BSKB), Kristi Sawert (USPTO), Peter Scott (WIPR)
Presentation preview: WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents
  • Channel
  • Channel profile
  • Saving money immediately on your IP assets: Auditing your trademark portfolio Recorded: Oct 26 2017 58 mins
    Guido Chiavelli (CEO, Il Gufo), Alessia Parassina (Lawyer, Brandstock), Angela La Marca (IP counsel) Ed Conlon (WIPR),
    With the year approaching its end, many IP departments will be looking at how best to rationalise their work for 2018. This webinar explores how to ensure your trademark portfolio is in the best possible shape using a two part verification and audit process to save you time and money on your IP assets, as well as analyzing your current and planned costs and guiding your filing strategy in the new year.
  • WIPR and RWS IP Services present: 10 Steps for Managing Your Patents in China Recorded: Oct 17 2017 42 mins
    Caroline Chenique (Global Director of Sales & Marketing, RWS), Justin Simpson (RWS, founder of inovia) and Ed Conlon (WIPR)
    Join WIPR and RWS IP Services for a complimentary webinar as we discuss patent filing strategies in China.

    As the largest growing consumer market in the world, enforcing your intellectual property (IP) in China has become increasingly critical. In this webinar, we will discuss the ten steps your organization should take when seeking patent protection and help you formulate your commercial IP strategy.
  • WIPR and HGF present: Biotech patentability issues in Europe Recorded: Sep 27 2017 58 mins
    Iain Armstrong (Partner, HGF), Dr. Laurence Gainey (Patent Director, HGF) and Peter Scott (Publisher, WIPR/LSIPR)
    This webinar will cover the current state of play in Europe regarding biotech patentability issues, including recent case law on what data you need to make an invention in this area plausible. It will also look at how recent rule changes have influenced patentability of plants and animals before the EPO. Finally, we will compare patentability practice in different jurisdictions around the world, most notably in the US, China and Japan.
  • The jungle of IP ownership: How to manage your IP Recordals Recorded: Jun 27 2017 59 mins
    Anna Popova (Brandstock), Ingo Dauer (L'Occitane en Provence), Sandra Hammelmann (Abbott), Peter Scott (WIPR)
    WIPR and Brandstock present this one hour webinar looking at IP recordals projects and the challenges brands face when undertaking this kind of work.
  • WIPR and BSKB present: The Halo effect: walking the willfulness tightrope Recorded: May 16 2017 57 mins
    Peter Scott (WIPR), Michael Mutter (BSKB), Shawn Hamidinia (BSKB)
    The US Supreme Court's recent decision in Halo Electronics, Inc. v. Pulse Electronics, Inc has big implications.

    This one-hour webinar will briefly address the history of willful infringement and the obligations to avoid infringement before and after the Seagate decision and as changed by Halo.

    It will also focus on how to best establish good faith with a non-infringement/invalidity position post-Halo including where a product was introduced post-Seagate and prior to Halo.
  • LSIPR and HGF present: Navigating the CRISPR IP landscape in Europe Recorded: Apr 25 2017 52 mins
    Dr Claire Irvine (HGF Ltd) Catherine Coombes (HGF Ltd), Peter Scott (Life Sciences IP Review)
    The CRISPR IP landscape in Europe is very murky. Listeners will gain an understanding of the current situation, which will aid them to make licensing decisions if and when they intend to commercialise. This 45-minute webinar will provide an up to date analysis of the current state of play in Europe with comparison to the state of play in the US.
  • WIPR and Brandstock present: Managing Business Risk: How Corporates do Searches Recorded: Nov 2 2016 57 mins
    Jayne McClelland (Syngenta International), Cedric Freymond (Nestlé), Alessia Lorenzini, (Brandstock), Peter Scott (WIPR)
    One of the main challenges companies face with their trademarks is managing business risk effectively. In this on-hour webinar, we hear from leading brands about how they minimise risk by developing smarter search strategies to ensure that their trademark portfolios are robust and effective.
  • WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents Recorded: Oct 13 2016 66 mins
    Gerald Murphy (BSKB), Eugene Perez (BSKB), Kristi Sawert (USPTO), Peter Scott (WIPR)
    Challenging patents involving unpredictable technologies for obviousness is particularly difficult due to the well-established factor of “reasonable expectation of success” and the related KSR factor of “limited number of predictable solutions”. This webinar, presented by attorneys that have successfully argued on both sides of this issue for chem/pharma/bio patents, will discuss two to three leading PTAB decisions, including related appeals, that illustrate when obviousness challenges have and have not been successful. The case discussions will provide (1) a summary of the documentary evidence relied on, including critical excerpts from that evidence, (2) a summary of the “story” that was being told by each party and (3) the role that expert testimony appeared to play in the PTAB decisions. This one-hour seminar will also briefly explore what types of cases are better challenged in court and what types of cases are better challenged at the PTAB. The goals of the seminar are to allow parties to evaluate the chances of success for a contemplated or recently filed PTAB challenge and to help parties to a PTAB proceeding develop a record to support their respective positions. CLE available.
  • WIPR and BSKB present -Disparaging marks: The Redskins, The Slants and the USPTO Recorded: May 11 2016 61 mins
    Robert Kenney (BSKB), John Ferman (BSKB), Professor Steven D. Jamar (Howard IP Program), Peter Scott (WIPR)
    When the Federal Circuit last year effectively struck down the portion of section 2(a) of the Lanham Act that bars so-called ‘disparaging’ trademarks in the US, it paved the way for a potential Supreme Court review of the issue. In this webinar, we discuss the implications of the decision, the case that prompted it, The Redskins, The Slants and other potentially ‘disparaging’ trademarks, and the implications for US practice. Robert Kenney and John Ferman from Birch Stewart Kolasch & Birch and Professor Steven D. Jamar from the Howard IP Program are joined by Peter Scott, to consider this controversial issue. We hope you’ll join us for a lively debate.

    1-hour long

    CLE available.
  • Manage worldwide risks with GfK geodata & CRESTA zones Recorded: Sep 3 2014 61 mins
    Christopher Guider, Matthias Hauschild, Chris Ewing
    Intelligent Insurer is hosting a free GfK webinar on September 3 from 3-4pm BST (London time) that shows how GfK boundary data and CRESTA zones support reinsurance applications. A use case by Aon Benfield Impact Forecasting demonstrates how GfK geodata helps the company develop catastrophe models and visualize exposures, hazards and risks.

    What you’ll learn from this webinar
    * How GfK geodata supports catastrophe model development
    * Why GfK boundary data offers distinct advantages for planning and managing risk
    * The benefits of using postal boundaries and CRESTA zones as a basis of planning

    Click the “Attend” button to register for this free webinar.

    Who should attend
    * Reinsurers and reinsurance companies and brokers
    * Risk model users
    * GIS users in a (re)insurance context
    * Anyone interested in how geodata supports the full spectrum of (re)insurance tasks

    The webinar is moderated by Wyn Jenkins, the group managing editor of Intelligent Insurer, and includes presentations by Matthias Hauschild, Senior Consultant at GfK; Christopher Guider, Marketing Manager at GfK; and Chris Ewing, Catastrophe Model Developer at Aon Benfield Impact Forecasting. GfK is a leading provider of administrative, postal and CRESTA boundary data specifically designed to support reinsurance applications.
Providing insight on Insurance, Reinsurance and Intellectual Property
Content for the home of Intelligent Insurer, Bermuda:RE+ILS, World IP Review, Life Sciences IP Review, Captive International and Healthcare Risk Management

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: WIPR and BSKB present: Obviousness in PTAB Trials for Chem/Pharma/Bio Patents
  • Live at: Oct 13 2016 3:30 pm
  • Presented by: Gerald Murphy (BSKB), Eugene Perez (BSKB), Kristi Sawert (USPTO), Peter Scott (WIPR)
  • From:
Your email has been sent.
or close